Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia.

Bartzokis G, Lu PH, Nuechterlein KH, Gitlin M, Doi C, Edwards N, Lieu C, Altshuler LL, Mintz J.

Schizophr Res. 2007 Jul;93(1-3):13-22. Epub 2007 Apr 3. Erratum in: Schizophr Res. 2008 Feb;99(1-3):379.

2.

Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.

Sampford JR, Sampson S, Li BG, Zhao S, Xia J, Furtado VA.

Cochrane Database Syst Rev. 2016 Jul 2;7:CD010832. doi: 10.1002/14651858.CD010832.pub2. Review.

PMID:
27370402
3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
4.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
5.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
6.

Fluphenazine decanoate (depot) and enanthate for schizophrenia.

Maayan N, Quraishi SN, David A, Jayaswal A, Eisenbruch M, Rathbone J, Asher R, Adams CE.

Cochrane Database Syst Rev. 2015 Feb 5;(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Review.

PMID:
25654768
7.

Olanzapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2. Review.

8.

Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.

Tardy M, Huhn M, Engel RR, Leucht S.

Cochrane Database Syst Rev. 2014 Aug 3;(8):CD009230. doi: 10.1002/14651858.CD009230.pub2. Review.

PMID:
25087165
9.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
10.

Clozapine versus other atypical antipsychotics for schizophrenia.

Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006633. doi: 10.1002/14651858.CD006633.pub2. Review.

11.

Risperidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2. Review.

12.

Depot fluphenazine decanoate and enanthate for schizophrenia.

David A, Adams CE, Eisenbruch M, Quraishi S, Rathbone J.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD000307. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD000307.

PMID:
15674872
13.

Atypical antipsychotics for disruptive behaviour disorders in children and youths.

Loy JH, Merry SN, Hetrick SE, Stasiak K.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Review.

PMID:
22972123
14.

Ziprasidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Bhoopathi PS, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2. Review.

15.

Amisulpride versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Silveira da Mota Neto JI, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006624. doi: 10.1002/14651858.CD006624.pub2. Review.

16.

Risperidone. A pharmacoeconomic review of its use in schizophrenia.

Foster RH, Goa KL.

Pharmacoeconomics. 1998 Jul;14(1):97-133. Review.

PMID:
10182198
17.

Risperidone (depot) for schizophrenia.

Sampson S, Hosalli P, Furtado VA, Davis JM.

Cochrane Database Syst Rev. 2016 Apr 14;4:CD004161. doi: 10.1002/14651858.CD004161.pub2. Review.

PMID:
27078222

Supplemental Content

Support Center